EUVIMEDEUVIMED entdecken
Crossref

Genetic Alterations Associated with Colistin Resistance Development in Escherichia coli

Fatemeh Alsahlani, Mehri Haeili

Microbial Drug Resistance · 2024

DOI: 10.1089/mdr.2024.0026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Drug Resistance, 2024. Verfasst von Fatemeh Alsahlani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran. Hauptthemen laut MEDLINE: Colistin, Escherichia coli, Microbial Sensitivity Tests, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The increased incidence of infections due to multidrug-resistant Gram-negative bacteria has led to the renewed interest in the use of ‘forgotten’ antibiotics such as colistin. In this work, we studied the chromosomal colistin resistance mechanisms among laboratory-induced colistin-resistant Escherichia coli isolates.

Methods

Three colistin-susceptible (ColS) clinical isolates of E. coli assigning to ST131, ST405, and ST361 were exposed to successively increasing concentrations of colistin. The nucleotide sequences of pmrA , pmrB , pmrD , phoP , phoQ , and mgrB genes were determined. The fitness burden associated with colistin resistance acquisition was determined by measuring the in vitro growth rate.

Results

Colistin resistance induction resulted in 16–64 times increase in colistin MICs in mutants ( n = 8) compared with parental isolates. Analysis of chromosomal genes in colistin-resistant mutants compared with those of ColS ancestors revealed genetic alterations confined to PmrAB two-component system and included PmrA G53R/R81S/L105P and PmrB E121K/E121A/A159P/A159V/G302E changes. The PmrB E121 was found as a critical position for colistin resistance development being altered in three mutants with different ancestors. The acquired colistin-resistance phenotype was stable following 10 consecutive passages in the absence of selective pressure of colistin and it did not alter the susceptibility of mutants to other antimicrobial agents. All mutants exhibited growth rates similar to their respective ColS ancestors, except for one isolate, which revealed a significant growth defect.

Conclusion

Our results revealed that colistin resistance in E. coli was more related to PmrAB alterations, which did not impose a fitness cost in most cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinEscherichia coliMicrobial Sensitivity TestsAnti-Bacterial AgentsDrug Resistance, BacterialEscherichia coli ProteinsMutationHumansEscherichia coli InfectionsDrug Resistance, Multiple, BacterialBacterial ProteinsTranscription Factors

Stichwörter der Autor:innen

Escherichia coliPmrAPmrBcolistin resistancefitness cost

Substanzen

ColistinAnti-Bacterial AgentsEscherichia coli ProteinsPmrB protein, bacteriaBacterial ProteinsTranscription Factors

Autor:innen und Institutionen

  • Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Zitieren

APA

Alsahlani, F., & Haeili, M. (2024). Genetic Alterations Associated with Colistin Resistance Development in Escherichia coli. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2024.0026

Vancouver

Alsahlani F, Haeili M. Genetic Alterations Associated with Colistin Resistance Development in Escherichia coli. Microbial Drug Resistance. 2024. doi:10.1089/mdr.2024.0026

BibTeX
@article{Alsahlani2024,
  author = {Alsahlani, Fatemeh and Haeili, Mehri},
  title = {Genetic Alterations Associated with Colistin Resistance Development in Escherichia coli},
  journal = {Microbial Drug Resistance},
  year = {2024},
  doi = {10.1089/mdr.2024.0026}
}
Kostenlos starten →